GCP
LIAN

GSA Capital Partners’s LianBio American Depositary Shares LIAN Stock Holding History

GSA Capital Partners’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,482
Closed -$32K – 2026
2022
Q4 		$32K Sell
19,482
-106,490
-85% -$166K ﹤0.01% 1379
2022
Q3 		$252K Buy
125,972
+29,388
+30% +$70.3K 0.03% 1046
2022
Q2 		$209K Buy
+96,584
New +$328K 0.03% 1052

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

GSA Capital Partners's LIAN Position: Q1 2023 in Review

GSA Capital Partners sold out of LianBio American Depositary Shares (LIAN) in Q1 2023, closing a stake of 19,482 shares — an estimated $32K sold.

GSA Capital Partners first reported a position in LIAN in Q2 2022 and held it in 3 quarters. The position peaked at $252K in Q3 2022. 36 funds tracked by Wall St. Rank hold LIAN as of Q1 2023.

  • GSA Capital Partners reported no remaining LianBio American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 19,482 LianBio American Depositary Shares shares in Q1 2023, an estimated $32K.
  • GSA Capital Partners first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 3 quarters.
  • GSA Capital Partners's LianBio American Depositary Shares position peaked at $252K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.